PubMed

Osteopenia: to treat or not to treat?

McClung MR.

Ann Intern Med. 2005 May 3;142(9):796-7. No abstract available. PMID: 15867413 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Cost-effectiveness of alendronate in postmenopausal women with low bone mass without osteoporosis or previous fracture.

[No authors listed]

Ann Intern Med. 2005 May 3;142(9):I36. No abstract available. PMID: 15867399 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women.

Schousboe JT, Nyman JA, Kane RL, Ensrud KE.

Ann Intern Med. 2005 May 3;142(9):734-41.PMID: 15867405 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia.

Meadows ES, Klein R, Rousculp MD, Smolen L, Ohsfeldt RL, Johnston JA.

BMC Womens Health. 2007 Apr 17;7:6.PMID: 17439652 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy.

Schousboe JT, Bauer DC, Nyman JA, Kane RL, Melton LJ, Ensrud KE.

Osteoporos Int. 2007 Feb;18(2):201-10. Epub 2006 Sep 20.PMID: 17019515 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of prevention of nonvertebral fractures by alendronate.

Prostko M.

JAMA. 1997 Aug 27;278(8):631; author reply 631-2. No abstract available. PMID: 9272886 [PubMed - indexed for MEDLINE]Related articles

[Cost effectiveness analysis of alendronate versus placebo in the prevention of hip fractures]

Hawkins Carranza F, López Alvarez MB.

Aten Primaria. 2000 Sep 15;26(4):274-5. Spanish. No abstract available. PMID: 11100590 [PubMed - indexed for MEDLINE]Related articlesFree article

The population of health economic models is critical.

Stevenson M.

Bone. 2008 Jul;43(1):214; author reply 215-6. Epub 2008 Mar 12. No abstract available. PMID: 18411076 [PubMed - indexed for MEDLINE]Related articles

Bone densitometry and treatment for osteoporosis in older men.

Ito K.

JAMA. 2007 Nov 14;298(18):2136-7; author reply 2137. No abstract available. PMID: 18000194 [PubMed - indexed for MEDLINE]Related articles

Clinical practice. Osteopenia.

Khosla S, Melton LJ 3rd.

N Engl J Med. 2007 May 31;356(22):2293-300. Review. No abstract available. PMID: 17538088 [PubMed - indexed for MEDLINE]Related articles

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J.

Health Technol Assess. 2005 Jun;9(22):1-160. Review.PMID: 15929857 [PubMed - indexed for MEDLINE]Related articlesFree article

Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term.

Suzuki Y, Ishibashi Y, Omura N, Kawasaki N, Kashiwagi H, Yanaga K, Abo M, Urashima M.

J Gastrointest Surg. 2005 Sep-Oct;9(7):955-60.PMID: 16137591 [PubMed - indexed for MEDLINE]Related articles

Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.

Schousboe JT, Ensrud KE, Nyman JA, Melton LJ 3rd, Kane RL.

J Am Geriatr Soc. 2005 Oct;53(10):1697-704.PMID: 16181168 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.

Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES, Melton LJ 3rd, Bauer DC, Ensrud KE.

JAMA. 2007 Aug 8;298(6):629-37.PMID: 17684185 [PubMed - indexed for MEDLINE]Related articlesFree article

Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.

Millonig G, Graziadei IW, Eichler D, Pfeiffer KP, Finkenstedt G, Muehllechner P, Koenigsrainer A, Margreiter R, Vogel W.

Liver Transpl. 2005 Aug;11(8):960-6.PMID: 16035083 [PubMed - indexed for MEDLINE]Related articlesFree article

Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland.

Schwenkglenks M, Lippuner K.

Osteoporos Int. 2007 Nov;18(11):1481-91. Epub 2007 May 26.PMID: 17530156 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.

Jansen JP, Gaugris S, Bergman G, Sen SS.

Curr Med Res Opin. 2008 Mar;24(3):671-84. Epub 2008 Jan 24.PMID: 18221588 [PubMed - indexed for MEDLINE]Related articles

Alendronic acid for antipsychotic-related osteopenia.

Howes O, Smith S.

Am J Psychiatry. 2004 Apr;161(4):756. No abstract available. PMID: 15056528 [PubMed - indexed for MEDLINE]Related articlesFree article

Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.

Tosteson AN, Burge RT, Marshall DA, Lindsay R.

Am J Manag Care. 2008 Sep;14(9):605-15.PMID: 18778176 [PubMed - indexed for MEDLINE]Related articlesFree article

Rethinking early bone-loss treatment.

[No authors listed]

Mayo Clin Health Lett. 2005 Sep;23(9):4. No abstract available. PMID: 16299838 [PubMed - indexed for MEDLINE]Related articles